The Clinical Measurement Ontology (CMO), Measurement Methods Ontology (MMO), and Experimental Condition Ontology (XCO) are currently being developed at the Rat Genome Database. For more information about these vocabularies please see Shimoyama et al. Three ontologies to define phenotype measurement data. Front Genet. 2012;3:87. Epub 2012 May 28 or contact us (http://rgd.mcw.edu/contact/index.shtml).
Term:
blood intermediate density lipoprotein phospholipid level
Measurement of the amount of phospholipid, any of various phosphorus-containing lipids that are composed mainly of fatty acids, a phosphate group, and a simple organic molecule such as glycerol, carried in intermediate-density lipoprotein (IDL) molecules in a specified volume of blood, the fluid that circulates through the heart, arteries, capillaries and veins carrying nutrients and oxygen to the body tissues and metabolites away from them. IDL are relatively large lipoprotein particles (complex molecules that consist of a protein membrane surrounding a core of lipids) formed by degradation of very low density lipoproteins (VLDL) particles and thus having a size intermediate between those of VLDL and low density lipoproteins. The IDL class of lipoproteins is defined as having a density between 1.006 and 1.019 g/ml.
Comment:
Values for density ranges of the lipoprotein classes are approximate. The classes may be defined differently by different researchers, in part because class definitions depend on the number of subclasses into which the lipoprotein fractions are divided.